GT Biopharma Inc Forecast, price target & analysts
$0.76
4.71%
today
Nasdaq,
Sep 25, 05:39 pm CET
GT Biopharma Inc Target price 2025 - Analyst rating & recommendation
Powered by
GT Biopharma Inc Classifications & Recommendation:
Buy
86%
Hold
14%
GT Biopharma Inc Price Target
| Target Price | $11.22 |
| Price | $0.80 |
| Potential |
1,302.68%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target GT Biopharma Inc 2026 .
The average GT Biopharma Inc target price is $11.22.
This is
1,302.68%
register free of charge
$11.55
1,343.93%
register free of charge
$11.11
1,288.92%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend GT Biopharma Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the GT Biopharma Inc stock has an average upside potential 2026 of
1,302.68%
register free of charge
|
Current GT Biopharma Inc Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Roth MKM |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Roth MKM:
Locked
➜
Locked
|
Dec 02 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
